Business
Allied Colombia Exceeds the 120th Employee Milestone in Its Company Growth Trajectory
Allied Colombia Exceeds the 120th Employee Milestone in Its Company Growth Trajectory.
About this update from Allied Corp.
[{"type":"text","content":"\n KELOWNA, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Allied Corp. (\"Allied\" or the “Company”) (OTCQB: ALID) is pleased to announce a milestone in its company growth trajectory. Allied Colombia SAS, a wholly owned subsidiary of Allied Corp, has now exceeded 120 full time employees. Over the past two years, Allied has been on a continual growth trajectory both in its production foot print as well as human resource complement. As Allied’s Colombian production has continued to scale in preparation of the opening of export of cannabis flower from Colombia, so has the number of people within the organization. Being a company of over 120 people now positions Allied to be able to handle the weekly production capacity needed to satisfy the international demand for the Allied Inside™ product. “We are excited to exceed this 120th person threshold. The Allied team is exceptional to say the least and having a strong team complement is extremely important to being able to offer what we believe to be consistent, quality output from the Colombian Campus. Motivated by a greater purpose of serving those who have given of their lives to serve their country, the Allied team continues to follow through on what we said we were going to accomplish,” said Mr. Calum Hughes, CEO and Chairman of Allied Corp. About Allied Corp. – CLICK HERE Click here for Allied Inside™ business model website: CLICK HERE Allied Corp. is an international cannabis company with its main production center in Colombia and is one of the few companies that has exported from Colombia internationally. In preparation for the possible legalization of cannabis by the US Federal Government, Allied also has the option to purchase a US cannabis license in the US (Nevada) exercisable if such were to happen. In addition to this, Allied has three CBD-brands to market with products selling in the United States. Lastly, Allied has both Cannabinoid and psilocybin products in the pharmaceutical development track seeking pharma drug indications for depression, anxiety and PTSD. Investor Relations:[email protected] Forward-Looking Statements:This press release contains “forward-looking information” within the meaning of applicable securities laws in Canada or the United States (“forward-looking inform...